| 000 | 02601nam a22003615i 4500 | ||
|---|---|---|---|
| 999 |
_c81384 _d81384 _x1 |
||
| 001 | 81384 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040327.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150624s2015 gw | s |||| 0|eng d | ||
| 020 | _a9783319162416 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRS380 _b.N663 2015 EB |
|
| 245 | 0 | 0 |
_aNon-Biological Complex Drugs : _bThe Science and the Regulatory Landscape _cedited by Daan J.A. Crommelin, Jon S. B. de Vlieger |
| 260 |
_aCham, Switzerland _bSpringer _c2015 |
||
| 300 | _a1 recurso en línea (IX, 390 p.) 91 il., 57 il. col. | ||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 1 |
_aAAPS Advances in the Pharmaceutical Sciences Series _x2210-7371 _v20 |
|
| 520 | _aThe rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests. This book is meant to be used for years to come as a standard reference work for the development of NBCDs.Â{u036F}reover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.Â{uE000} | ||
| 650 | 7 |
_aBiotecnología farmacéutica _9155839 _0comprobar BNE19996549239 _2embne |
|
| 700 |
_aCrommelin, Daan J. A. _eeditor literario _984705 _0Local |
||
| 700 | 1 |
_aVlieger, Jon S. B. de _eeditor literario _993770 _0Local |
|
| 830 | 0 |
_aAAPS Advances in the Pharmaceutical Sciences Series _x2210-7371 _v20 _9133175 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-16241-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783319162416 | ||
| 907 |
_a.b12899744 _b10-10-17 _c18-01-16 |
||
| 942 |
_2lcc _cLE |
||
| 945 |
_aRS380 .N663 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11569360 _z06-04-17 |
||
| 988 | _aEBOOK, EBSPRINGER | ||
| 998 |
_am _a_alco _a_vill _b13-03-17 _cm _dz _ek _feng _ggw _h0 |
||